iAnthus Capital Holdings (FRA:2IA) Change In Receivables: €3.1 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is iAnthus Capital Holdings Change In Receivables?

iAnthus Capital Holdings FRA:2IA Change In Receivables is €3.1 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

iAnthus Capital Holdings's change in receivables for the quarter that ended in Mar. 2026 was €-0.1 Mil. It means iAnthus Capital Holdings's Accounts Receivable increased by €0.1 Mil from Dec. 2025 to Mar. 2026 .

iAnthus Capital Holdings's change in receivables for the fiscal year that ended in Dec. 2025 was €3.7 Mil. It means iAnthus Capital Holdings's Accounts Receivable declined by €3.7 Mil from Dec. 2024 to Dec. 2025 .

iAnthus Capital Holdings's Accounts Receivable for the quarter that ended in Mar. 2026 was €5.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. iAnthus Capital Holdings's Days Sales Outstanding for the three months ended in Mar. 2026 was 18.38.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. iAnthus Capital Holdings's liquidation value for the three months ended in Mar. 2026 was €-297.7 Mil.

iAnthus Capital Holdings  (FRA:2IA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

iAnthus Capital Holdings's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=5.839/28.986*91
=18.38

2. In Ben Graham's calculation of liquidation value, iAnthus Capital Holdings's accounts receivable are only considered to be worth 75% of book value:

iAnthus Capital Holdings's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=9.633-322.373+0.75 * 5.839+0.5 * 21.238
=-297.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iAnthus Capital Holdings Change In Receivables Related Terms

iAnthus Capital Holdings Change In Receivables Historical Data

* Premium members only.

The historical data trend for iAnthus Capital Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iAnthus Capital Holdings Change In Receivables Chart

iAnthus Capital Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.14 -0.44 -0.76 -1.68 3.73

iAnthus Capital Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 4.31 -0.65 -0.45 -0.09

iAnthus Capital Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €3.1 Mil mean?
iAnthus Capital Holdings (FRA:2IA) has a Change In Receivables of €3.1 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for iAnthus Capital Holdings and its competitors.
Is iAnthus Capital Holdings' Change In Receivables too high?
iAnthus Capital Holdings' current Change In Receivables is €3.1 Mil.
How does iAnthus Capital Holdings' Change In Receivables compare to ZTS?
iAnthus Capital Holdings' Change In Receivables of €3.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for iAnthus Capital Holdings and its competitors. iAnthus Capital Holdings's current Change In Receivables is €3.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iAnthus Capital Holdings stock overvalued right now?
iAnthus Capital Holdings (FRA:2IA) has a current Change In Receivables of €3.1 Mil. The current Change In Receivables is €3.1 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For iAnthus Capital Holdings (FRA:2IA), the current Change In Receivables is €3.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

iAnthus Capital Holdings Business Description

Other Exchanges ITHUF:USAIAN:Canada
Address 214 King Street West, Suite 314, Toronto, ON, CAN, M5H 3S6
iAnthus Capital Holdings Inc is a vertically-integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities and a developer, producer, and distributor of branded cannabis products in the United States. Its Cannabis product offerings include flower and trim, products containing cannabis flower and trim (such as packaged flower and pre-rolls), cannabis infused products (such as topical creams and edibles), and products containing cannabis extracts (such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures). The company's reportable operating segments are the Eastern Region, which generates the maximum revenue, and the Western Region.